We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BX:NYSEBlackstone Inc. Analysis

Data as of 2026-06-14 - not real-time

$122.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Blackstone Inc. (BX) is trading at $122.79, well above its DCF‑derived fair value of $33.50, indicating a substantial valuation premium. The stock sits below its 20‑day ($117.25) and 50‑day ($120.31) simple moving averages and far under the 200‑day SMA ($140.24), confirming a bearish technical backdrop. Momentum is mixed: the RSI of 56.5 suggests neutral pressure, while the MACD histogram is positive (0.79) despite a negative MACD line, hinting at a potential short‑term bounce toward the resistance level of $124.98. Volatility remains high at 39.5% over the past 30 days and beta of 1.44 signals heightened sensitivity to market moves. Fundamentals show a robust ROE of 29.5% and a solid cash position of $2.6 bn, but a payout ratio of 121% raises concerns about dividend sustainability. Recent material news, including a $35 bn financing deal with Anthropic and a joint AI‑cloud venture with Google, provides a growth catalyst that could support earnings expansion in the medium term.
Given the overvaluation, elevated risk metrics, and dividend strain, the short‑term outlook is cautious, but the firm’s diversified asset base and strategic AI partnerships may justify a more optimistic medium‑term stance. Long‑term investors should monitor the firm’s ability to translate high‑growth initiatives into cash generation while managing leverage, as the current price reflects a significant premium over intrinsic estimates.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish price trend relative to moving averages
  • High valuation premium to DCF fair value
  • Dividend payout exceeds earnings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic AI and cloud partnership with Google/Anthropic
  • Strong ROE and cash generation capacity
  • Potential earnings acceleration from alternative credit deals

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Diversified global asset portfolio
  • Sustained leverage and debt levels
  • Uncertainty around dividend sustainability and valuation correction

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin21.21%
P/E Ratio31.5
ROE29.53%
ROA13.03%
Debt/Equity72.02
P/B Ratio11.5
Op. Cash Flow$4.5B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI56.5
Support$107.03
Resistance$124.98
MA 20$117.25
MA 50$120.31
MA 200$140.24
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$33.50
Target Price$143.45
Upside/Downside16.83%
GradeOvervalued
TypeBlend
Dividend Yield4.05%

Risk Assessment

Beta1.44
Volatility39.50%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.